USP7: The Double-Edged Deubiquitinase That Tumors Cannot Live Without
A new review in Cancer Cell International maps how the deubiquitinase USP7 acts as both tumor promoter and suppressor depending ...
A new review in Cancer Cell International maps how the deubiquitinase USP7 acts as both tumor promoter and suppressor depending ...
Researchers fused machine learning, molecular docking and molecular dynamics simulations into a virtual screening pipeline that discovered HY-18,623, a nanomolar ...
A computational screen of 698 plant compounds identified diosgenin as a stronger and safer binder of antiapoptotic Bcl-2 family proteins ...
A diterpenoid-rich fraction prepared from the roots of the Turkish sage Salvia oligophylla induced programmed cell death in MCF-7 breast ...
Dr. Cristina Puig-Saus and her research team at the UCLA Health Jonsson Comprehensive Cancer Center have received a five-year, $3.9 ...
The arduous journey of developing effective cancer drugs, marked by high costs and prolonged timelines, is undergoing a transformative shift ...
In a groundbreaking study published on November 5, 2025, in npj Precision Oncology, researchers from Sanford Burnham Prebys Medical Discovery ...
For the first time, scientists have made a groundbreaking advance in cancer research by developing drug candidates that bind irreversibly ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine